The National Human Genome Research Institute (NHGRI) has appointed Carolyn Hutter, Ph.D. the director of the Division of Genome Sciences - the NHGRI division that leads research aiming to understand the function of the human genome in health and disease, and seeks technologies that facilitate genomic discoveries. Dr. Hutter comes to the position with extensive experience leading large-scale genomics research programs.
The National Human Genome Research Institute today launched a new round of strategic planning that will establish a 2020 vision for genomics research aimed at accelerating scientific and medical breakthroughs. In developing the strategic plan, the institute will engage experts and diverse public communities to identify paradigm-shifting areas of genomics that will expand the field into new frontiers and enable novel applications to human health and disease.
Researchers and clinicians are sequencing human genomes faster than ever, so considering the societal implications of genomic data and what we can learn from it is even more crucial. On January 29, 2018, NHGRI hosted a Reddit "Ask Me Anything" (AMA) with program directors from the Ethical, Legal and Societal Implications research program and NHGRI policy experts. Questions ran the gamut of who owns an individual's DNA and the information stored in it, to the implications of genetic testing for children and newborns.
This month's The Genomics Landscape features stories about the appointment of Carolyn Hutter, Ph.D., as the new director of NHGRI's Division of Genome Sciences; the appointment of Alex Azar as secretary of the Department of Health and Human Services; an upcoming webcast to announce NHGRI's new strategic planning process and the loss of Dr. Arno Motulsky, a prominent and highly accomplished human and medical geneticist, and a founder of the field of pharmacogenomics.
Antibiotic-resistant organisms can be found on hospital countertops, doorknobs, computers, sinks and even inside the plumbing. Investigators at the National Institutes of Health (NIH) recently conducted whole genome sequencing on samples from pipes beneath the NIH Clinical Center. The majority of samples from pipes and sewers tested positive for bacterial plasmids that confer resistance to the "last-resort" antibiotics given to hospital patients who develop infections from pathogens that are multidrug-resistant. The study was published Feb. 6, 2018 in mBio.